Why I’m Considering Canopy Growth Stock For My RRSP

As the cannabis industry grows, adding Canopy Growth stock to my RRSP will give me access to massive upside.

| More on:
A cannabis plant grows.

Source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

From the moment we start working, we hear constant messaging about the importance of saving for retirement. While it’s easy to agree, finding the right investments for an RRSP is a much more complicated proposition. So I would like to share with you why I considered Canopy Growth Corp. (TSX:WEED)(NASDAQ:CGC) as a candidate for my RRSP.

Here are three reasons why I’m finally warming up to the infamous cannabis stock today.

Cannabis stocks have been outperforming in August as U.S. legalization legislation advances

So maybe I’m not the only one whose warming up to these stocks. I mean, cannabis stocks have been on fire in August. For example, Canopy Growth stock is up 38%. Also, Aurora Cannabis Inc. (TSX:ACB)(NASDAQ:ACB) rose almost 30% in August.

Canopy growth stock aurora cannabis stock RRSP

Don’t get me wrong, I’m aware that these stocks have been disasters. The cannabis stock bubble burst a few years ago. This caused tremendous losses for many. So today, investors are no longer enamoured by these stocks. They’ve been burned.

The one good thing about this scenario is that cannabis stock valuations are no longer in bubble-territory. They’ve gone from trading at 100-plus times sales to now trading at levels that I can stomach. Canopy Growth stock, for example, is currently trading at four times sales. Aurora Cannabis stock is trading at two times sales. The more reasonable valuations mean I am comfortable considering them for my RRSP.

Canopy Growth shows long-term promise as a leader in the industry

In Canada, Canopy maintains the number one position in market share in premium products. Also, progress in being made in focusing and streamlining the business. In the latest quarter, Canopy demonstrated stabilized revenue and market share performance, and improved cash margins. This was largely attributed to the company’s focus on premium products as well as cost savings.

Total revenue for the quarter was $110 million. This was a 19% decline versus last year BUT an only 1% decline versus last quarter. Strong demand and record sales growth for Biosteel products helped. As a reminder, Biosteel sells sports hydration drink products. It has secured shelf space at Walmart. Also, additional retailers are showing strong interest. For now, the Walmart deal means that Biosteel will be available at 2,200 Walmart stores.

Canopy Growth has placed a big bet on the U.S. market. The company believes that it will be the largest cannabis market in the world. And while progress here has been slower than anticipated, two-thirds of Americans live in an area that has access to cannabis products. And legalization is moving forward, albeit at a snail’s pace.

Despite cash burn, Canopy Growth has built up a solid balance sheet

Cash burn is always concerning. But looking beyond that, I see many encouraging bits of information. Firstly, Canopy has $1.2 billion in cash. It also has US$500 million of available debt capacity. Lastly, proceeds from the company’s sale of different facilities have yet to be received.

So, the cannabis industry is still in its infancy. This means that investors must have patience. But remember, the cannabis industry still has great potential. It’s a product that meets the needs and desires of many, so analyst estimates of a global cannabis industry market size of $28 billion in 2021 makes sense.  And that it’s expected to grow significantly in the next few years. Some estimates are calling for annual growth rates of 30% plus.

Thus, all market indications are that there will be room for many in this industry. But, it’s extremely difficult to predict which cannabis company will survive and thrive the most. One way to go about getting exposure to the cannabis industry in your RRSP is to buy a basket of cannabis stocks. Aurora Cannabis stock is another solid Canadian option. With a basket, we can weed out the company-specific risks while still having exposure to the overall industry trend.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Karen Thomas has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »